January 10th, 2012
Announcement no. 01
Announcement from major shareholder
BioPorto A/S has been informed that T. Bernt Nielsen A/S and associates have reduced their ownership below 5% of the share capital in BioPorto A/S.
Further details:
Frank Harder, CFO
Tel: +45 4529 0000
E-mail: investor@bioporto.com
March 31, 2026Announcement no. 6 BioPorto Advances U.S. Adult Urine NGAL Program with FDA Pre-Submission Request After Positive EPACRA AKI Cut Off Analysis COPENHAGEN, DENMARK, 31 March 2026 –...
Read MoreMarch 31, 2026News Release KDIGO publishes 2026 Clinical Practice Guideline Draft for Acute Kidney Injury and Acute Kidney Disease COPENHAGEN, DENMARK, 31 March 2026 – BioPorto A/S (“BioPorto” or...
Read More